VOR
Vor Biopharma Inc.
$20.59
+2.20 (+11.96%)
At close · Jul 2
Market Cap
$1.12B
Shares
54,185,877
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$20.59
Open$18.72
Day$18.67–22.22
52W$6.50–65.80
Avg vol 30d1.3M
Short int6.0M · 11.0% float · 7.1d
Short vol42%
Last earningsJan 12, 2026
DataFeb 2021–Jul 2026
Filing10-Q · May 13
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Buy
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+21% above
+
Price vs 50-day avg
+37% above
−
RSI (14)
78 · overbought
+
MACD trend
positive
◦
52-week position
24% · mid-range
Sentiment · smart money
Neutral
◦
Trend (MA cross)
50d $15 › 200d $17 — 200d above 50d
+
Institutional flow
+43% holders QoQ · +35 funds added
−
Insider flow
Net -$34.9M over 90 days · 100% sells
−
Short interest
10.98% of float · ▲ +23.5% MoM · 7.1 days cover
◦
Volume signal
Volume near normal
+
Institution breadth
80 holders — near 1-yr high, broad support
Fundamentals
Weak
−
EPS growth
−107% Y/Y
−
Free cash flow
$-143.7M
+
Balance sheet
net cash $396.5M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 13, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+21% above
Bullish
Price vs 50-day avg
+37% above
Bullish
RSI (14)
78 · overbought
Bearish
MACD trend
positive
Bullish
52-week position
24% · mid-range
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $15 › 200d $17 — 200d above 50d
Institutional flow
Accumulating
+43% holders QoQ · +35 funds added
Insider flow
Distributing
Net -$34.9M over 90 days · 100% sells
Short interest
Rising
10.98% of float · ▲ +23.5% MoM · 7.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
80 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $7
Now $21 · 24%
52-wk high $66
vs 200-day avg +21%
vs 50-day avg +37%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VOR
this stock
Vor Biopharma Inc.
|
$1.12B | +57.4% | — | — | 11.0% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VOR | +37.9% | +53.2% | +61.1% | +11.8% | +57.4% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +36.5% | +54.5% | +53.1% | +12.1% | +48.2% |